The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Glycomics & Glycobiology Market Research Report 2024

Global Glycomics & Glycobiology Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1704594

No of Pages : 86

Synopsis
Glycomics is the comprehensive study of glycomes (the entire complement of sugars, whether free or present in more complex molecules of an organism), including genetic, physiologic, pathologic, and other aspects. Glycomics "is the systematic study of all glycan structures of a given cell type or organism" and is a subset of glycobiology. The term glycomics is derived from the chemical prefix for sweetness or a sugar, "glyco-", and was formed to follow the naming convention established by genomics (which deals with genes) and proteomics (which deals with proteins).

Glycobiology is fast emerging as a primary field of interest for biomolecular and biomedical research around the globe. Once considered merely supporting structures, the sugars have now been widely recognized to be a vital component in running the complex machinery of life itself.
The global Glycomics & Glycobiology market was valued at US$ 1143 million in 2023 and is anticipated to reach US$ 2470.4 million by 2030, witnessing a CAGR of 11.5% during the forecast period 2024-2030.
Global Glycomics/Glycobiology key players include ThermoFisher Scientific, Danaher, Shimadzu Corporation, ProZyme, etc. Global top four manufacturers hold a share over 15%.
North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both have a share about 50 percent.
In terms of product, Instruments is the largest segment, with a share about 33%. And in terms of application, the largest application is Drug Discovery & Development, followed by Diagnostics, etc.
This report aims to provide a comprehensive presentation of the global market for Glycomics & Glycobiology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glycomics & Glycobiology.
Report Scope
The Glycomics & Glycobiology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glycomics & Glycobiology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glycomics & Glycobiology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ThermoFisher Scientific
Danaher
Shimadzu Corporation
ProZyme
Takara Bio, Inc.
Agilent Technologies
Bruker
Promega
Waters Corporation
R&D Systems
New England Biolabs
Merck KGaA
Segment by Type
Instruments
Enzymes
Reagents
Kits
Segment by Application
Drug Discovery & Development
Diagnostics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Glycomics & Glycobiology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Glycomics & Glycobiology Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Instruments
1.2.3 Enzymes
1.2.4 Reagents
1.2.5 Kits
1.3 Market by Application
1.3.1 Global Glycomics & Glycobiology Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Drug Discovery & Development
1.3.3 Diagnostics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Glycomics & Glycobiology Market Perspective (2019-2030)
2.2 Glycomics & Glycobiology Growth Trends by Region
2.2.1 Global Glycomics & Glycobiology Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Glycomics & Glycobiology Historic Market Size by Region (2019-2024)
2.2.3 Glycomics & Glycobiology Forecasted Market Size by Region (2025-2030)
2.3 Glycomics & Glycobiology Market Dynamics
2.3.1 Glycomics & Glycobiology Industry Trends
2.3.2 Glycomics & Glycobiology Market Drivers
2.3.3 Glycomics & Glycobiology Market Challenges
2.3.4 Glycomics & Glycobiology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Glycomics & Glycobiology Players by Revenue
3.1.1 Global Top Glycomics & Glycobiology Players by Revenue (2019-2024)
3.1.2 Global Glycomics & Glycobiology Revenue Market Share by Players (2019-2024)
3.2 Global Glycomics & Glycobiology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Glycomics & Glycobiology Revenue
3.4 Global Glycomics & Glycobiology Market Concentration Ratio
3.4.1 Global Glycomics & Glycobiology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Glycomics & Glycobiology Revenue in 2023
3.5 Glycomics & Glycobiology Key Players Head office and Area Served
3.6 Key Players Glycomics & Glycobiology Product Solution and Service
3.7 Date of Enter into Glycomics & Glycobiology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Glycomics & Glycobiology Breakdown Data by Type
4.1 Global Glycomics & Glycobiology Historic Market Size by Type (2019-2024)
4.2 Global Glycomics & Glycobiology Forecasted Market Size by Type (2025-2030)
5 Glycomics & Glycobiology Breakdown Data by Application
5.1 Global Glycomics & Glycobiology Historic Market Size by Application (2019-2024)
5.2 Global Glycomics & Glycobiology Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Glycomics & Glycobiology Market Size (2019-2030)
6.2 North America Glycomics & Glycobiology Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Glycomics & Glycobiology Market Size by Country (2019-2024)
6.4 North America Glycomics & Glycobiology Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Glycomics & Glycobiology Market Size (2019-2030)
7.2 Europe Glycomics & Glycobiology Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Glycomics & Glycobiology Market Size by Country (2019-2024)
7.4 Europe Glycomics & Glycobiology Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Glycomics & Glycobiology Market Size (2019-2030)
8.2 Asia-Pacific Glycomics & Glycobiology Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Glycomics & Glycobiology Market Size by Region (2019-2024)
8.4 Asia-Pacific Glycomics & Glycobiology Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Glycomics & Glycobiology Market Size (2019-2030)
9.2 Latin America Glycomics & Glycobiology Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Glycomics & Glycobiology Market Size by Country (2019-2024)
9.4 Latin America Glycomics & Glycobiology Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Glycomics & Glycobiology Market Size (2019-2030)
10.2 Middle East & Africa Glycomics & Glycobiology Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Glycomics & Glycobiology Market Size by Country (2019-2024)
10.4 Middle East & Africa Glycomics & Glycobiology Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ThermoFisher Scientific
11.1.1 ThermoFisher Scientific Company Detail
11.1.2 ThermoFisher Scientific Business Overview
11.1.3 ThermoFisher Scientific Glycomics & Glycobiology Introduction
11.1.4 ThermoFisher Scientific Revenue in Glycomics & Glycobiology Business (2019-2024)
11.1.5 ThermoFisher Scientific Recent Development
11.2 Danaher
11.2.1 Danaher Company Detail
11.2.2 Danaher Business Overview
11.2.3 Danaher Glycomics & Glycobiology Introduction
11.2.4 Danaher Revenue in Glycomics & Glycobiology Business (2019-2024)
11.2.5 Danaher Recent Development
11.3 Shimadzu Corporation
11.3.1 Shimadzu Corporation Company Detail
11.3.2 Shimadzu Corporation Business Overview
11.3.3 Shimadzu Corporation Glycomics & Glycobiology Introduction
11.3.4 Shimadzu Corporation Revenue in Glycomics & Glycobiology Business (2019-2024)
11.3.5 Shimadzu Corporation Recent Development
11.4 ProZyme
11.4.1 ProZyme Company Detail
11.4.2 ProZyme Business Overview
11.4.3 ProZyme Glycomics & Glycobiology Introduction
11.4.4 ProZyme Revenue in Glycomics & Glycobiology Business (2019-2024)
11.4.5 ProZyme Recent Development
11.5 Takara Bio, Inc.
11.5.1 Takara Bio, Inc. Company Detail
11.5.2 Takara Bio, Inc. Business Overview
11.5.3 Takara Bio, Inc. Glycomics & Glycobiology Introduction
11.5.4 Takara Bio, Inc. Revenue in Glycomics & Glycobiology Business (2019-2024)
11.5.5 Takara Bio, Inc. Recent Development
11.6 Agilent Technologies
11.6.1 Agilent Technologies Company Detail
11.6.2 Agilent Technologies Business Overview
11.6.3 Agilent Technologies Glycomics & Glycobiology Introduction
11.6.4 Agilent Technologies Revenue in Glycomics & Glycobiology Business (2019-2024)
11.6.5 Agilent Technologies Recent Development
11.7 Bruker
11.7.1 Bruker Company Detail
11.7.2 Bruker Business Overview
11.7.3 Bruker Glycomics & Glycobiology Introduction
11.7.4 Bruker Revenue in Glycomics & Glycobiology Business (2019-2024)
11.7.5 Bruker Recent Development
11.8 Promega
11.8.1 Promega Company Detail
11.8.2 Promega Business Overview
11.8.3 Promega Glycomics & Glycobiology Introduction
11.8.4 Promega Revenue in Glycomics & Glycobiology Business (2019-2024)
11.8.5 Promega Recent Development
11.9 Waters Corporation
11.9.1 Waters Corporation Company Detail
11.9.2 Waters Corporation Business Overview
11.9.3 Waters Corporation Glycomics & Glycobiology Introduction
11.9.4 Waters Corporation Revenue in Glycomics & Glycobiology Business (2019-2024)
11.9.5 Waters Corporation Recent Development
11.10 R&D Systems
11.10.1 R&D Systems Company Detail
11.10.2 R&D Systems Business Overview
11.10.3 R&D Systems Glycomics & Glycobiology Introduction
11.10.4 R&D Systems Revenue in Glycomics & Glycobiology Business (2019-2024)
11.10.5 R&D Systems Recent Development
11.11 New England Biolabs
11.11.1 New England Biolabs Company Detail
11.11.2 New England Biolabs Business Overview
11.11.3 New England Biolabs Glycomics & Glycobiology Introduction
11.11.4 New England Biolabs Revenue in Glycomics & Glycobiology Business (2019-2024)
11.11.5 New England Biolabs Recent Development
11.12 Merck KGaA
11.12.1 Merck KGaA Company Detail
11.12.2 Merck KGaA Business Overview
11.12.3 Merck KGaA Glycomics & Glycobiology Introduction
11.12.4 Merck KGaA Revenue in Glycomics & Glycobiology Business (2019-2024)
11.12.5 Merck KGaA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’